Roux-en-Y Gastric Bypass, and the role of Leptin

RYGB is not only as an effective therapeutic modality for the treatment of morbid obesity, but to be used to improve our knowledge on the etiology of obesity and type 2 diabetes whose epidemic proportions represent one of the greatest challenges to healthcare systems in the decades to come. We consider RYGB not only as an effective therapeutic modality for the treatment of morbid obesity, but to be used to improve our knowledge on the etiology of obesity and type 2 diabetes whose epidemic proportions represent one of the greatest challenges to healthcare systems in the decades to come